Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyWed, 17 Jul 2024 06:50:42 +0200Fri, 05 Jul 2024 15:46:00 +0200Opinion/decision on a Paediatric investigation plan (PIP): Ontozry, cenobamate, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Neurology, PIP number: P/0214/2023https://www.ema.europa.eu/en/medicines/human/paediatric-investigation-plans/emea-002563-pip02-19-m02Opinion/decision on a Paediatric investigation plan (PIP): Ontozry, cenobamate, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Neurology, PIP number: P/0214/2023https://www.ema.europa.eu/en/medicines/human/paediatric-investigation-plans/emea-002563-pip02-19-m02Fri, 05 Jul 2024 15:46:00 +0200Human medicineHuman medicines European public assessment report (EPAR): Ontozry, cenobamate, Date of authorisation: 26/03/2021, Revision: 7, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/ontozryHuman medicines European public assessment report (EPAR): Ontozry, cenobamate, Date of authorisation: 26/03/2021, Revision: 7, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/ontozryTue, 23 Apr 2024 16:19:00 +0200Human medicineOntozry : EPAR - Public assessment reporthttps://www.ema.europa.eu/system/files/documents/assessment-report/h-5377-par_en.pdfOntozry : EPAR - Public assessment reporthttps://www.ema.europa.eu/system/files/documents/assessment-report/h-5377-par_en.pdfTue, 13 Apr 2021 15:38:00 +0200Human medicine